ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Abbott To Supply Quest With Immunoassay Tests.

September 29, 2000

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994

Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180

March 26, 1982

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

NCAB Urges $2 Tax On Cigarettes To Reduce Smoking

February 12, 1993